{"symbol": "GENE", "companyName": "Genetic Technologies Ltd", "exchange": "NASDAQ Capital Market", "industry": "Medical Diagnostics & Research", "website": "http://www.gtglabs.com", "description": "Genetic Technologies Ltd is a molecular diagnostics company which offers predictive testing and assessment tools to help physicians manage women's health. It has developed BREVAGenplus, which is a is a clinically validated risk assessment test.", "CEO": "Paul A. Kasian", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Diagnostics & Research", "Medical Diagnostics & Research"]}